← SynDRA
GSK1904529A
SynDRA canonical compound SYN1970475 — structure-anchored drug synonym record
Clinical phase
Preclinical
Primary target(s)
IGF1R | INSR
Mechanism of action
IGF-1 inhibitor | insulin growth factor receptor inhibitor | insulin receptor ligand
All known targets
IGF1R
INSR
Mechanisms of action (all sources)
IGF-1 inhibitor
insulin growth factor receptor inhibitor
insulin receptor ligand
Cross-references
PubChem CID:
25124816
Synonyms
GSK 1904529A
N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide
CHEMBL466397
IGF-1R inhibitor GS1904529A
N-(2,6-difluorophenyl)-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonylpiperazin-1-yl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide
N-(2,6-difluorophenyl)-5-(3-{2-[(5-ethyl-2-(methyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide
MLS006010966
SCHEMBL309890
CHEBI:91401
DTXSID70648776
EX-A008
HMS3295G13
HMS3654G19
AMY24202
GSK 4529
BDBM50256480
MFCD17010271
NSC767951
s1093
AKOS030238962
ZINC150338709
CCG-264817
EX-8674
NSC-767951
SB19376
NCGC00253439-01
NCGC00253439-04
AC-28459
AS-17030
HY-10524
N-(2,6-difluorophenyl)-5-(3-(2-((5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide
N-(2,6-difluorophenyl)-5-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide
N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-
SMR004702770
FT-0733738
SW219610-1
EC-000.2336
GSK 1904529A (GSK 4529)
A24618
Look up GSK1904529A in the interactive SynDRA portal →